Print This Story  Email This Story  Save this Link View PR Newswire's RSS Feed  Blogs Discussing this News Release  Search Blogs that Mention this News Release  Click this link to view linked Bookmarking Services Click this link to view linked Blogging Services


Synova Healthcare, Inc. Announces Appointment of Chief Financial Officer

    MEDIA, Pa., Sept. 21 /PRNewswire-FirstCall/ -- Synova Healthcare Inc, a
wholly owned subsidiary of Synova Healthcare Group, Inc. (Pink Sheets: SNVH),
today announced that it has appointed Mr. Robert Edwards as Chief Financial
Officer to oversee all financial reporting and accounting activities across
the Company's operations.
    Mr. Edwards joins the Synova team bringing more than 20 years of rich
experience, having developed his business acumen in finance and accounting
while working with start-up companies, international and domestic companies,
as well as publicly traded companies.  His previous roles have included
Controller and Treasurer with K-tron International, Chief Financial Officer
and Controller with ABB Traction Inc., Controller with FMC Corporation, and
most recently Chief Executive Officer at Colortronic, Inc.  Mr. Edwards holds
a Bachelor of Science from Northern Arizona University, and has successfully
completed competition and strategy courses at the Harvard University Business
School.
    During his career, Mr. Edwards has been responsible for a wide variety of
financial and general management functions, including organizational
development, investor relations, finance, operations and strategic
acquisitions.  As a high-performance leader, Mr. Edwards is a valuable
addition to the Synova management team.

    About Synova Healthcare Group, Inc.:
    Synova Healthcare Group, Inc., (SNVH), presently operates two wholly owned
subsidiaries; Synova Healthcare, Inc. and Synova Pre-Natal Healthcare, Inc.
The company distributes rapid, non-invasive medical diagnostics to retail for
over-the-counter (OTC) use, and directly to health care providers for point of
care (POC) use in the clinical setting.  The company's products are designed
to improve human health and quality of life by providing early and accurate
awareness of the onset of certain medical conditions.

    This Press Release may contain certain forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of 1995.  The
Company has tried, whenever possible, to identify these forward-looking
statements using words such as "anticipates," "believes," "estimates,"
"expects," "plans," "intends," "potential" and similar expressions.  These
statements reflect the Company's current beliefs and are based upon
information currently available to it.  Accordingly, such forward-looking
statements involve known and unknown risks, uncertainties and other factors
which could cause the Company's actual results, performance or achievements to
differ materially from those expressed in or implied by such statements.
There can be no assurance that such factors will not affect the accuracy of
such forward-looking statements.  The Company undertakes no obligation to
update or advise in the event of any change, addition or alteration to the
information set forth in this Press Release including such forward-looking
statements. This press release does not constitute an offer to sell or the
solicitation of an offer to buy; nor will there be any sale of securities of
Synova Healthcare Group, Inc. in any state where such offer, solicitation or
sale would be unlawful before registration or qualification under the
securities laws of those states.


SOURCE Synova Healthcare, Inc.




Back to Topback to top

Related links:
  • http://www.synovahealthcare.com
    CONTACT:
    Synova Healthcare Group, Inc, Tel:
    +1-610-565-7080, Fax: +1-610-565-7081,
    customerservice@synovahealthcare.com